LHCQX Fees and Costs — Lord Abbett Health Care Fund, Class R3
Data updated: 2026-09-25
The net expense ratio is 1.28%: a 0.62% management fee, a 0.50% 12b-1 fee plus 2.61% other expenses, less a 2.45% fee waiver. There are no sales loads or redemption fees. In fiscal 2025 the fund paid $6K in broker commissions, 0.0711% of average net assets, and portfolio turnover was 91%.
LHCQX Fees and Expenses
Annual operating expenses and sales charges of LHCQX. Prospectus, as of October 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.62% |
| 12b-1 fee | 0.50% |
| Other expenses | 2.61% |
| Gross expense ratio | 3.73% |
| Fee waiver | −2.45% |
| Net expense ratio | 1.28% |
| Sales charges | |
|---|---|
| Max front load | 0.00% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
LHCQX Costs Over Time
On $10,000 invested in LHCQX, assuming 5% a year before costs, total costs come to $839 over 5 years, cutting the return by 1.42% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 1.28%) | $134 | $418 | $722 |
| Trading costs (broker commissions) | $7 | $23 | $40 |
| Lost growth on money paid in costs | $0 | $22 | $77 |
| Total costs | $142 | $463 | $839 |
| Value after costs | $10,358 | $11,113 | $11,924 |
| Impact on return, per year | 1.42% | 1.42% | 1.42% |
LHCQX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending October 31, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.0711%
- Total broker commissions: $6K
- Bought from dealers (principal trades, not a cost): $33.0M
- Portfolio turnover (prospectus): 91%
- Securities on loan, average value: $24K
- Net income from securities lending: $1K (0.013% of average net assets)
LHCQX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| J.P. Morgan Securities LLC | $2K | 31.87% |
| BofA Securities, Inc. | $997 | 21.14% |
| UBS Securities LLC | $613 | 13.00% |
| Jefferies LLC | $350 | 7.41% |
| Morgan Stanley & Co. LLC | $248 | 5.27% |
| BNP Paribas Securities Corp. | $231 | 4.89% |
| William Blair & Company, L.L.C. | $230 | 4.87% |
| Barclays Capital Inc. | $214 | 4.53% |
| Goldman Sachs & Co. LLC | $172 | 3.66% |
| Evercore Group L.L.C. | $159 | 3.37% |
LHCQX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| State Street Bank and Trust Company | $32.8M | 99.57% |
| Barclays Capital Inc. | $48K | 0.15% |
| Jefferies LLC | $48K | 0.15% |
| Goldman Sachs & Co. LLC | $23K | 0.07% |
| J.P. Morgan Securities LLC | $12K | 0.04% |
| Piper Sandler & Co. | $9K | 0.03% |
| Leerink Partners LLC | $2K | 0.01% |
Lord Abbett Health Care Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| LHCOX | Class F3 | 0.68% | none |
| LHCVX | Class R6 | 0.68% | none |
| LHCFX | Class F | 0.78% | none |
| LHCIX | Class I | 0.78% | none |
| LHCTX | Class R5 | 0.78% | none |
| LHCAX | Class A | 1.03% | 5.75% |
| LHCSX | Class R4 | 1.03% | none |
| LHCQX | Class R3 | 1.28% | none |
| LHCCX | Class C | 1.78% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.